{"prompt": "['Tofacitinib', 'A3921284 NON-INTERVENTIONAL STUDY PROTOCOL', 'Amended, 12-December-2018', '26.', 'Almoallim H, Kamil A. Rheumatoid arthritis: should we shift the focus from \"Treat', 'to Target\" to \"Treat to Work?\". Clin Rheumatol. 2013 Mar;32(3):285-7.', '27.', 'Reilly Associates. WPAI Translations: (Rheumatoid Arthritis) v2.0 [Internet]. [cited', '2016 Mar 21]. Available from: :http://www.reillyassociates.net/WPAI_Translations-', '2.html', '28.', 'Pincus T, Swearingen CJ, Bergman M, Yazici Y. RAPID3 (Routine Assessment of', 'Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for', 'routine care: proposed severity categories compared to disease activity score and', 'clinical disease activity index categories. J Rheumatol. 2008 Nov;35(11):2136-47', '29.', 'Maldonado Ficco H, P\u00e9rez Alamino RS SE, Al. E. Validaci\u00f3n del cuestionario', 'RAPID3 en una cohorte de pacientes con artritis reumatoidea temprana y', 'establecida, y su correlaci\u00f3n con otros \u00edndices de actividad. Rev Arg Reum.', '011;22(2):31-9.', '30.', \"Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van\", 'Riel PL. Modified disease activity scores that include twenty-eight-joint counts.', 'Development and validation in a prospective longitudinal study of patients with', 'rheumatoid arthritis. Arthritis Rheum. 1995 Jan;38(1):44-8.', '31.', 'Anderson J, Caplan L, Yazdany J, Robbins ML, Neogi T, Michaud K, et al.', 'Rheumatoid arthritis disease activity measures: American College of Rheumatology', 'recommendations for use in clinical practice. Arthritis Care Res (Hoboken). 2012', 'May;64(5):640-7.', '32.', 'ICH HARMONISED TRIPARTITE GUIDELINE. GUIDELINE FOR GOOD', 'CLINICAL PRACTICE E6(R1). 1996.', '33.', 'World Health Organization. Uppsala Monitoring Centre. The use of the WHO-UMC', 'system for standardized case causality assessment [Internet]. [cited 2016 May 12].', 'Available from: http://who-umc.org/Graphics/24734.pdf', '34.', 'U.S. Department of Health and Human Services. Common Terminology Criteria for', 'Adverse Events (CTCAE) [Internet]. 2010. Available from:', 'http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-', '14_QuickReference_5x7.pdf', '35.', 'Austin PC. Optimal caliper widths for propensity-score matching when estimating', 'differences in means and differences in proportions in observational studies. Pharm', 'Stat. 2011 Mar; 10(2):150-61.', '17. LIST OF TABLES', 'Not applicable', 'Page 47 of 64']['Tofacitinib', 'A3921284 NON-INTERVENTIONAL STUDY PROTOCOL', 'Amended, 12-December-2018', 'ANNEX 1. LIST OF STAND ALONE DOCUMENTS', 'Document', 'reference', 'Number', 'number', 'Date', 'Title', '1', 'NA', 'Data Collection Form', 'CONFIDENTIAL', 'Page 48 of 64']\n\n###\n\n", "completion": "END"}